Research
Roth Capital Initiates Exagen at Buy With $8 Price Target
Exagen (XGN) has an average rating of buy and mean price target of $8.57, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$XGN
